30 Biggest Movers From Friday

Gainers

• Longfin Corp. LFIN shares surged 47.3 percent to close at $28.189 on Friday after climbing 64.86 percent on Thursday.
• Genprex, Inc. GNPX jumped 31.74 percent to close at $5.45 on Friday.
• Broadwind Energy, Inc. BWEN shares gained 28.94 percent to close at $3.03 after the company disclosed that it has recently booked $10 million in new tower orders and Gearing segment orders of $15 million in Q1.
• Marrone Bio Innovations, Inc. MBII shares jumped 21.72 percent to close at $3.25.
• NuCana plc NCNA shares gained 16.94 percent to close at $26.23.
• CASI Pharmaceuticals, Inc. CASI shares rose 13.98 percent to close at $7.01 on Friday.
• FTD Companies, Inc. FTD shares climbed 13.33 percent to close at $5.10.
• GOL Linhas Aéreas Inteligentes S.A. GOL shares gained 12.97 percent to close at $14.11 on Friday. Bank of America upgraded Gol Linhas from Neutral to Buy.
• Pacira Pharmaceuticals, Inc. PCRX shares rose 12.88 percent to close at $33.30. Pacira reported the FDA approval of supplemental new drug application for EXPAREL.
• Radiant Logistics, Inc. RLGT gained 10.08 percent to close at $4.04.
• Freshpet, Inc. FRPT shares rose 10.06 percent to close at $18.05 on Friday.
• BIO-key International, Inc. BKYI shares gained 9.59 percent to close at $2.40.
• NII Holdings, Inc. NIHD shares climbed 6.61 percent to close at $2.42.
• PriceSmart, Inc. PSMT gained 5.5 percent to close at $88.225 after the company reported stronger-than-expected results for its second quarter on Thursday.

Losers

• NewLink Genetics Corporation NLNK shares tumbled 42.62 percent to close at $4.20 on Friday.
• MannKind Corporation MNKD fell 24.79 percent to close at $1.79. MannKind priced its 14 million share registered direct offering at $2 per share.
• Incyte Corporation INCY declined 22.93 percent to close at $64.02 after the company , announced Friday a disappointing update to a phase 3 trial. Incyte said its experimental therapy called epacadostat failed in a phase 3 trial called ECHO-301 to improve the efficacy of Merck & Co's Keytruda when the two therapies were combined to treat patients suffering from melanoma.
• Allena Pharmaceuticals, Inc. ALNA shares dipped 19.5 percent to close at $12.67.
• Innovate Biopharmaceuticals, Inc. INNT tumbled 19.21 percent to close at $27.68.
• Syndax Pharmaceuticals, Inc. SNDX shares fell 18.74 percent to close at $10.84.
• Boston Omaha Corporation BOMN shares dipped 17.86 percent to close at $22.40.
• Net Element, Inc. NETE shares fell 17.36 percent to close at $7.33 on Friday after jumping 32.98 percent on Thursday.
• Luna Innovations Incorporated LUNA shares dropped 15.92 percent to close at $3.17.
• Finjan Holdings, Inc. FNJN fell 15.68 percent to close at $2.85.
• Northern Oil and Gas, Inc. NOG dipped 14.45 percent to close at $1.48. Northern Oil and Gas priced 58.67 million shares at $1.50 per share.
• Sunrun Inc. RUN shares fell 14.29 percent to close at $8.52. Bank of America downgraded Sunrun from Buy to Underperform.
• resTORbio, Inc. TORC fell 11.29 percent to close at $8.49.
• Iteris, Inc. ITI shares fell 9.46 percent to close at $4.50 on Friday.
• New Media Investment Group Inc. NEWM fell 6.38 percent to close at $16.30. New Media Investment Group priced its 6 million share offering at $16.5 per share.
• ORBCOMM Inc ORBC fell 4.01 percent to close at $8.85. ORBCOMM priced its 3 million share common stock offering at $8.60 per share.